WSLHD
Skip navigation
Please use this identifier to cite or link to this item: https://wslhd.intersearch.com.au/wslhdjspui/handle/1/8393
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShek, Dmitrii-
dc.contributor.authorAhlenstiel, Golo-
dc.date.accessioned2024-01-23T05:02:03Z-
dc.date.available2024-01-23T05:02:03Z-
dc.date.issued2023-
dc.identifier.citationChinese Clinical Oncology 12(5):47, 2023-
dc.identifier.urihttps://wslhd.intersearch.com.au/wslhdjspui/handle/1/8393-
dc.subjectOncology-
dc.subjectHepatology-
dc.titlePembrolizumab: a potential game-changer in the treatment of advanced hepatocellular carcinoma-
dc.typeJournal Article-
dc.identifier.doihttps://dx.doi.org/10.21037/cco-23-44-
dc.subject.keywordsCarcinoma, Hepatocellular-
dc.subject.keywordsLiver Neoplasms-
dc.subject.keywordsAntibodies, Monoclonal, Humanized-
dc.identifier.journaltitleChinese Clinical Oncology-
dc.identifier.departmentOncology-
dc.identifier.departmentGastroenterology and Hepatology-
dc.contributor.wslhdShek, Dmitrii-
dc.contributor.wslhdAhlenstiel, Golo-
dc.identifier.pmid37691347-
dc.identifier.affiliationWestmead Institute for Medical Research, Sydney, NSW, Australia-
dc.identifier.affiliationBlacktown Mt Druitt Hospital, Sydney, NSW, Australia-
dc.identifier.facilityBlacktown-
dc.identifier.facilityMount Druitt-
dc.identifier.facilityWestmead-
dc.identifier.facilityAuburn-
Appears in Collections:Blacktown Mount Druitt Hospital

Files in This Item:
There are no files associated with this item.


Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.